Neurological Sciences

Article	Citations
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients	242
The neurological manifestations of COVID-19: a review article	188
Neuromuscular presentations in patients with COVID-19	160
Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions	141
Spectrum of neurological complications following COVID-19 vaccination	140
Acute stroke management pathway during Coronavirus-19 pandemic	139
Dementia care and COVID-19 pandemic: a necessary digital revolution	134
A prospective clinical study of detailed neurological manifestations in patients with COVID-19	133
Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital	116
Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports	76
West syndrome: a comprehensive review	72
New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases	70
Early neurological manifestations of hospitalized COVID-19 patients	68
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome	68
Long-term neurological manifestations of COVID-19: prevalence and predictive factors	68
Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study	66
Dysphagia in neurological diseases: a literature review	63
Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2	62
Neuropathologic findings of patients with COVID-19: a systematic review	59
Physical exercise effects on the brain during COVID-19 pandemic: links between mental and cardiovascular health	58
Gender-related differences in migraine	57
Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer’s disease populations	57
Assessing disability and relapses in multiple sclerosis on tele-neurology	57
Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients	55
Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy	54

Seizure in patients with COVID-19	53
Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19	50
COVID-19, de novo seizures, and epilepsy: a systematic review	50
Brainstem involvement and respiratory failure in COVID-19	46
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients	46
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine	45
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study	45
Hereditary spastic paraplegia	45
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters	43
Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic	43
Management of COVID-19 in people with epilepsy: drug considerations	41
Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy	41
Qualitative smell/taste disorders as sequelae of acute COVID-19	41
Diagnosis and treatment of Chiari malformation and syringomyelia in adults: international consensus document	41
An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)	41
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine	40
No lockdown for neurological diseases during COVID19 pandemic infection	39
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail	39
Related risk factors associated with post-stroke fatigue: a systematic review and meta-analysis	39
Early outcomes of migraine after erenumab discontinuation: data from a real-life setting	38
Effect of lockdown on the management of ischemic stroke: an Italian experience from a COVID hospital	38
Effect of home-based virtual reality training and telerehabilitation on balance in individuals with Parkinson disease, multiple sclerosis, and stroke: a systematic review and meta-analysis	38
The role of peripheral monocytes and macrophages in ischemic stroke	38
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6	38
Cumulative risk of stroke recurrence over the last 10 years: a systematic review and meta-analysis	38
Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline	37
Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review	37
Cognitive impairment in multiple sclerosis: diagnosis and monitoring	35
Neurological manifestations of coronavirus disease 2019: exploring past to understand present	35
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab	35
Hereditary transthyretin amyloidosis overview	35
Functional neurological disorder after COVID-19 vaccination	34
Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19	34
Epilepsy and quality of life: what does really matter?	34
Impact of COVID-19 on stroke admissions, treatments, and outcomes at a comprehensive stroke centre in the United Kingdom	32
The effect of obstructive sleep apnea on the increased risk of cardiovascular disease: a systematic review and meta-analysis	32
Electroencephalography at the time of Covid-19 pandemic in Italy	32
Effectiveness of ketogenic diet in treatment of patients with refractory chronic migraine	31
The role of microglia in the development of neurodegeneration	31
Subjective cognitive failures and their psychological correlates in a large Italian sample during quarantine/self-isolation for COVID-19	29
Clinical and neurophysiological characterization of muscular weakness in severe COVID-19	29
New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report	29
Post-Traumatic Stress Disorder After Traumatic Brain Injury—A Systematic Review and Meta-Analysis	29
Functional movement disorders in a patient with COVID-19	29
Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19	29
Stroke and digital technology: a wake-up call from COVID-19 pandemic	28
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study	28
Investigation of the peripheral inflammation (neutrophil–lymphocyte ratio) in two neurodegenerative diseases of the central nervous system	28
Spinocerebellar ataxia type 48: last but not least	27
New daily persistent headache after SARS-CoV-2 infection: a report of two cases	27

Current application of cannabidiol (CBD) in the management and treatment of neurological disorders	27
Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)	26
Structural and functional connections between the autonomic nervous system, hypothalamic–pituitary–adrenal axis, and the immune system: a context and time dependent stress response network	26
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis	26
COVID-19-related strokes in adults below 55 years of age: a case series	26
The vessel density of the superficial retinal capillary plexus as a new biomarker in cerebral small vessel disease: an optical coherence tomography angiography study	25
Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine	25
Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19	25
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic	25
Peripheral neuropathy in Parkinson’s disease	25
Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine	25
Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache	25
Diagnosis and treatment of Chiari malformation type 1 in children: the International Consensus Document	24
Cardiovascular autonomic dysfunction after stroke	24
The impact of lockdown during SARS-CoV-2 outbreak on behavioral and psychological symptoms of dementia	24
Letter to editor: CoVID-19 pandemic and sleep disorders—a web survey in Italy	24
The emotional impact of COVID-19 outbreak in amyotrophic lateral sclerosis patients: evaluation of depression, anxiety and interoceptive awareness	23
Psychometrics and diagnostics of Italian cognitive screening tests: a systematic review	23
Neuronavigation based 10 sessions of repetitive transcranial magnetic stimulation therapy in chronic migraine: an exploratory study	23
Rising evidence for neurological involvement in COVID-19 pandemic	23
Miller Fisher syndrome following Pfizer COVID-19 vaccine	23
The Frontal Assessment Battery 20 years later: normative data for a shortened version (FAB15)	23
Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review	23
A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson’s disease	22
Neuralgic amyotrophy associated with COVID-19 infection: a case report and review of the literature	22
The stroke mothership model survived during COVID-19 era: an observational single-center study in Emilia-Romagna, Italy	22
Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors	21
Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study	21
Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases	21
NOTCH2NLC-related repeat expansion disorders: an expanding group of neurodegenerative disorders	21
First motor seizure as presenting symptom of SARS-CoV-2 infection	21
Incidence of stroke among Saudi population: a systematic review and meta-analysis	21
Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis	21
Parkinson’s disease and virtual reality rehabilitation: cognitive reserve influences the walking and balance outcome	21
Clinical presentation of strokes confined to the insula: a systematic review of literature	21
How to manage with telemedicine people with neuromuscular diseases?	21
Reliability of the six-minute walk test in individuals with stroke: systematic review and meta-analysis	20
Transcranial magnetic stimulation implementation on stroke prognosis	20
Effect of small vessel disease burden and lacunes on gait/posture impairment in Parkinson’s disease	20
Cognitive telerehabilitation in neurological patients: systematic review and meta-analysis	20
Sex and gender differences in migraines: a narrative review	20
Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes	20
Chemotherapy and peripheral neuropathy	20
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era	20
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19	20
An overview on amyotrophic lateral sclerosis and cadmium	20
Clinical utility of home videos for diagnosing epileptic seizures: a systematic review and practical recommendations for optimal and safe recording	19
ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination	19
Alzheimer’s disease: the controversial approval of Aducanumab	19
Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study	19
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study	19
Functional autonomy in dementia of the Alzheimer’s type, mild cognitive impairment, and healthy aging: a meta-analysis	19
Age- and gender-related differences in the evolution of psychological and cognitive status after the lockdown for the COVID-19 outbreak: a follow-up study	19
Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the I	19
Why is delirium more frequent in the elderly?	19
Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study	19
Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions	19
Evaluation of an upper limb robotic rehabilitation program on motor functions, quality of life, cognition, and emotional status in patients with stroke: a randomized controlled study	19
Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment	18
Erenumab efficacy in highly resistant chronic migraine: a real-life study	18
Frontal lobe metabolic alterations characterizing Parkinson’s disease cognitive impairment	18
Endovascular treatment of ischemic large-vessel stroke due to infective endocarditis: case series and review of the literature	18
The surgical treatment of epilepsy	18
Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients	18
The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data	18
Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy	18
The links between diabetes mellitus and amyotrophic lateral sclerosis	18
Clinical phenotypes of embolic strokes of undetermined source	18
Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke	18
Covid-19-associated acute haemorrhagic leukoencephalomyelitis	17
Headache and pleocytosis in CSF associated with COVID-19: case report	17
Norms and standardizations in neuropsychology via equivalent scores: software solutions and practical guides	17
Can Systemic Immune-Inflammation Index (SII) be a prognostic factor of Bell’s palsy patients?	17
Thiazolidinedione use is associated with reduced risk of Parkinson’s disease in patients with diabetes: a meta-analysis of real-world evidence	17
Deep brain stimulation in Huntington’s disease: a literature review	17
Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs	17
Association of gender and age at onset with glucocerebrosidase associated Parkinson’s disease: a systematic review and meta-analysis	17
Neurological reasons for consultation and hospitalization during the COVID-19 pandemic	17
Non-motor symptoms are associated with REM sleep behavior disorder in Parkinson’s disease: a systematic review and meta-analysis	17
“When should primary angiitis of the central nervous system (PACNS) be suspected?”: literature review and proposal of a preliminary screening algorithm	17

Bell’s palsy following COVID-19 vaccination with high CSF antibody response	17
The case of encephalitis in a COVID-19 pediatric patient	17
Impact of COVID-19 on neurological manifestations: an overview of stroke presentation in pandemic	17
Impact of COVID-19 pandemic on acute stroke care: facing an epidemiological paradox with a paradigm shift	17
Diaphragmatic myoclonus due to SARS-CoV-2 infection	17
Dynamic functional connectivity in temporal lobe epilepsy: a graph theoretical and machine learning approach	17
Neuroanatomical changes in early Parkinson’s disease with mild cognitive impairment: a VBM study; the Parkinson’s Disease Cognitive Impairment Study (PaCoS)	17
Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysio	16
Factors affecting the behavior of children with ASD during the first outbreak of the COVID-19 pandemic	16
Parkinson’s disease and COVID-19: a systematic review and meta-analysis	16
Neurological toll of COVID-19	16
Hearing loss and dementia: radiologic and biomolecular basis of their shared characteristics. A systematic review.	16
Acutely altered mental status as the main clinical presentation of multiple strokes in critically ill patients with COVID-19	16
LncRNAs as putative biomarkers and therapeutic targets for Parkinson’s disease	16
Effectiveness of a dance-physiotherapy combined intervention in Parkinson’s disease: a randomized controlled pilot trial	16
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice	16
A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients	16
Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study	16
One year experience with erenumab: real-life data in 30 consecutive patients	16
Neurological manifestations and comorbidity associated with COVID-19: an overview	16
Do serum GDNF levels correlate with severity of Alzheimer’s disease?	16
Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience	16
Central nervous system adverse events after ChAdOx1 vaccination	16
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic	16
Contrast-induced encephalopathy mimicking total anterior circulation stroke: a case report and review of the literature	16
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience	16
Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?	16
Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis	15
Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis	15
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study	15
Pearls and pitfalls in brain functional analysis by event-related potentials: a narrative review by the Italian Psychophysiology and Cognitive Neuroscience Society on methodological limits and clinica	15
Brain microvascular occlusive disorder in COVID-19: a case report	15
Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody–associated encephalomyelitis: a case report and review o	15
A novel computed tomography perfusion-based quantitative tool for evaluation of perfusional abnormalities in migrainous aura stroke mimic	15
Urinary kynurenine as a biomarker for Parkinson’s disease	15
COVID-19 presenting with agraphia and conduction aphasia in a patient with left-hemisphere ischemic stroke	15
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)	15
Mechanical thrombectomy in acute ischemic stroke due to large vessel occlusion in the anterior circulation and low baseline National Institute of Health Stroke Scale score: a multicenter retrospective	15
Neurological manifestation of 22q11.2 deletion syndrome	15
A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms	15
Erenumab in 159 high frequency and chronic migraine patients: real-life results from the Bologna Headache Center	15
Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series	15
Chronic migraine in the first COVID-19 lockdown: the impact of sleep, remote working, and other life/psychological changes	15
Gepants — a long way to cure: a narrative review	15
Shear wave elastography characteristics of upper limb muscle in rigidity-dominant Parkinson’s disease	15
The Italian technical/administrative recommendations for telemedicine in clinical neurophysiology	15
MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development	15
Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study	15
Short- and long-term motor outcome of STN-DBS in Parkinson’s Disease: focus on sex differences	14
Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features?	14
Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study	14
Air pollution and multiple sclerosis: a comprehensive review	14
High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients	14
The efficacy of ultrasound-guided stellate ganglion block in alleviating postoperative pain and ventricular arrhythmias and its application prospects	14
Tele-neuropsychological assessment tools in Italy: a systematic review on psychometric properties and usability	14
COVID-19 in patients with Down syndrome	14
Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?	14
Favourable course in a cohort of Parkinson’s disease patients infected by SARS-CoV-2: a single-centre experience	14
Intra- and postoperative adverse events in awake craniotomy for intrinsic supratentorial brain tumors	14
The Frontal Assessment Battery (FAB) and its sub-scales: validation and updated normative data in an Italian population sample	14
Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy	14
Sensory stimulation to improve arousal in comatose patients after traumatic brain injury: a systematic review of the literature	14
Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases	14
Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures	14
Post-acute sequelae of SARS-CoV-2 infection (PASC): peripheral, autonomic, and central nervous system features in a child	14
Daily exposure to digital displays may affect the clock-drawing test: from psychometrics to serendipity	14
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson’s disease patients: a prospective longitudinal study	14
Factors associated with temporal window failure in transcranial Doppler sonography	14
Understanding patients’ and caregivers’ perspectives and educational needs in Parkinson’s disease: a multi-ethnic Asian study	14
The influence of statin withdrawal and adherence on stroke outcomes	14
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables	14
Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the Global Burden of Disease Study 2017	14
MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy	14
The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype	13
ADEM post-Sars-CoV-2 infection in a pediatric patient with Fisher-Evans syndrome	13
Headache after COVID-19 vaccination: updated report from the Italian Medicines Agency database	13
NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis	13
A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes	13
Diagnosing herpes simplex-1 encephalitis at the time of COVID-19 pandemic	13
Influence of the gut microbiome on inflammatory and immune response after stroke	13
Pupil dilation as an indicator of future thinking	13
Effectiveness of pharmacologic treatment for dysphagia in Parkinson’s disease: a narrative review	13
A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia	13
Bilateral optic neuritis after COVID vaccination	13
Imaging and depression in multiple sclerosis: a historical perspective	13
Improving care of chronic pain patients with spinal cord stimulator therapy amidst the opioid epidemic	13
Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data	13
Spontaneous intracranial hypotension: key features for a frequently misdiagnosed disorder	13
Sex influences clinical phenotype in frontotemporal dementia	13
Cyclophosphamide treatment in active multiple sclerosis	13
Detection of MOG-IgG by cell-based assay: moving from discovery to clinical practice	13
The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis	13
Which are the factors influencing NIV adaptation and tolerance in ALS patients?	13
Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?	13
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study	12